PRIORI, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 2.363
EU - Europa 1.137
AS - Asia 733
SA - Sud America 48
AF - Africa 34
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.324
Nazione #
US - Stati Uniti d'America 2.321
IT - Italia 578
SG - Singapore 442
SE - Svezia 126
IN - India 119
CN - Cina 111
DE - Germania 90
RU - Federazione Russa 68
FI - Finlandia 48
CA - Canada 37
AT - Austria 35
GB - Regno Unito 32
BR - Brasile 30
IE - Irlanda 27
TG - Togo 26
UA - Ucraina 26
ID - Indonesia 24
BG - Bulgaria 23
NL - Olanda 14
RO - Romania 13
BE - Belgio 11
FR - Francia 11
AR - Argentina 9
JP - Giappone 8
MK - Macedonia 8
ES - Italia 7
AU - Australia 6
DK - Danimarca 6
GR - Grecia 5
KR - Corea 5
CO - Colombia 4
PH - Filippine 4
BD - Bangladesh 3
CL - Cile 3
EG - Egitto 3
IL - Israele 3
MX - Messico 3
TR - Turchia 3
BZ - Belize 2
HK - Hong Kong 2
LT - Lituania 2
MY - Malesia 2
VE - Venezuela 2
ZA - Sudafrica 2
AL - Albania 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
EU - Europa 1
GA - Gabon 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SI - Slovenia 1
TH - Thailandia 1
VN - Vietnam 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.324
Città #
Fairfield 330
Chandler 220
Singapore 215
Rome 214
Ashburn 148
Woodbridge 132
Houston 127
Seattle 123
Cambridge 111
Wilmington 105
Santa Clara 92
Dearborn 81
San Paolo di Civitate 73
Ann Arbor 67
Princeton 67
Lawrence 52
Milan 51
Millbury 49
San Diego 42
Plano 36
New York 33
Dublin 26
Lomé 26
Helsinki 25
Beijing 23
Jakarta 23
Sofia 23
Vienna 23
Andover 19
Boston 16
Ottawa 16
San Gregorio da Sassola 15
Toronto 15
Moscow 14
Nuremberg 14
Brussels 11
Fremont 11
Boardman 10
Guangzhou 10
Los Angeles 10
Falkenstein 9
London 9
Norwalk 9
Palermo 9
San Mateo 9
Cosenza 8
Council Bluffs 8
Florence 8
Falls Church 7
Federal 7
Frankfurt am Main 6
Jacksonville 6
Mannheim 6
Naples 6
Padova 6
Lappeenranta 5
Phoenix 5
Yubileyny 5
Fiumicino 4
Hefei 4
Medellín 4
Nanjing 4
New Britain 4
Pune 4
Shanghai 4
Amsterdam 3
Bari 3
Bologna 3
Bühl 3
Dallas 3
Des Moines 3
Farra di Soligo 3
Frosinone 3
Hackney 3
Kumamoto 3
Las Vegas 3
Latina 3
Lisbon 3
McKinney 3
Munich 3
Osaka 3
Paris 3
Turin 3
Washington 3
Albano Laziale 2
Altenberg bei Linz 2
Ancona 2
Athens 2
Barquisimeto 2
Berlin 2
Bremen 2
Brescia 2
Carapelle 2
Castelfranco Emilia 2
Changzhou 2
Cheadle 2
Concórdia 2
Crotone 2
Foggia 2
Foligno 2
Totale 2.943
Nome #
Psoriasis and psoriatic arthritis-related uveitis: different ophthalmological manifestations and ocular inflammation features 149
Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome. 126
Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study 118
1H-NMR-Based Metabolomic Study for Identifying Serum Profiles Associated with the Response to Etanercept in Patients with Rheumatoid Arthritis 114
Porphyromonas gingivalis in the tongue biofilm is associated with the clinical outcome in rheumatoid arthritis patients 108
Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy 102
CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren’s syndrome patients and correlates with focus score and disease activity 88
Quality of sexual life in women with primary Sjögren syndrome 87
COVID-19 in italian sjögren's syndrome patients. a monocentric study 86
Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis 85
Immunohistochemical detection of IL-17 and IL-23 improves the identification of patients with a possible diagnosis of Sjogren's syndrome 85
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 84
Effectiveness and safety of baricitinib in rheumatoid arthritis. a monocentric, longitudinal, real-life experience 84
STAT4, TRAF3IP2, IL10, and HCP5 polymorphisms in sjögren's syndrome. association with disease susceptibility and clinical aspects 83
Inflammatory myopathies and overlap syndromes: Update on histological and serological profile 82
"In sickness and in health": the peculiar occurrence of polymyalgia rheumatica in married cohabiting couples-a case series and review of the literature. 82
HEARING DYSFUNCTION IN SJOGREN'S SYNDROME 80
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 78
Cryoglobulinemia in Sjögren syndrome: A disease subset that links higher systemic disease activity, autoimmunity, and local B Cell proliferation in mucosa-associated lymphoid tissue 78
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 77
Capitolo 9.8 Malattia IgG4-correlata 75
Multicolor flow cytometric analysis of TLR2 and TLR9 expression and function in NK cells from patients with ANCA-associated vasculitis 74
Sex differences in Sjögren's syndrome: A comprehensive review of immune mechanisms 74
Long-Term retention rate of anakinra in adult onset still's disease and predictive factors for treatment response 72
CXCL13 as biomarker for histological involvement in Sjögren's syndrome 72
A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: A nationwide multi-center retrospective observational study 69
Diagnosis of catastrophic anti-phospholipid syndrome in a patient tested negative for conventional tests 68
null 67
An unusual manifestation of IgG4-related disease 66
Erratum. management of adult-onset still's disease with interleukin-1 inhibitors. evidence- and consensus-based statements by a panel of Italian experts 66
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases. a message for rheumatologists 66
NMR-based metabolomics approach to study urines of chronic inflammatory rheumatic diseases patients. 65
Maladaptive autophagy in the pathogenesis of autoimmune epithelitis in Sjögren's syndrome 64
Phosphatidylinositol 3-kinase delta pathway a novel therapeutic target for sjögren's syndrome 63
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 60
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI) 59
Autophagy occurs in lymphocytes infiltrating sjögren’s syndrome minor salivary glands and correlates with histological severity of salivary gland lesions 59
Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus 59
Comparison of early vs. delayed anakinra treatment in patients with adult onset still's disease and effect on clinical and laboratory outcomes 58
Myositis in primary Sjögren's syndrome: data from a multicentre cohort 57
Soluble intercellular adhesion molecule-1 in a geographical cluster of scleroderma. 56
Qualitative mucin disorders in patients with primary Sjögren's syndrome: a literature review 55
Protenuria in SLE: is it always lupus? 55
Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors 54
null 53
Response to. cCorrespondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases. a message for rheumatologists'' by smerilli et al 51
Imaging activated-T-lymphocytes in the salivary glands of patients with sjögren’s syndrome by 99mTc-interleukin-2. diagnostic and therapeutic implications 50
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 50
Adult-onset Still's disease: Not always so good 49
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study 48
Sleep quality in patients with primary Sjögren's syndrome 46
Capitolo 7.6 Spondiloartriti enteropatiche 46
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors. results from a monocentric cohort 46
Correlation between ESSDAI and ClinESSDAI in a real-life cohort of patients with Sjögren's syndrome 45
Resilience in women with primary Sjögren’s syndrome 45
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population 45
Targeting the immune system for pulmonary iInflammation and cardiovascular complications in COVID-19 patients 42
The growing role of precision medicine for the treatment of autoimmune diseases. results of a systematic review of literature and experts’ consensus 42
Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies sjögren's syndrome with ectopic germinal centres and MALT lymphoma 41
Multicentre case-control study evaluating the safety of anti-SARS-CoV-2 vaccines in a cohort of patients with systemic vasculitis 39
Validation of thymic stromal lymphopoietin as a biomarker of primary sjogren's syndrome and related lymphoproliferation. results in independent cohorts 38
Cutaneous vasculitis following COVID-19 vaccination 38
Management of adult-onset Still's disease with interleukin-1 inhibitors.evidence- and consensus-based statements by a panel of Italian experts 36
The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients with Sjögren's Syndrome: Comment on the Article by Nocturne et al 34
OP0082 Expression of Fractalkine in Sjögren’s Syndrome Patients: Cellular and Molecular Characterization of CX3CL1 and CX3CR1 in Sera and Salivary Glands 34
TNFAIP3 gene polymorphisms in three common autoimmune diseases. systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in italian patients 33
Involvement of substance P (SP) and its related NK1 receptor in primary Sjögren’s syndrome (pSS) pathogenesis 30
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission 30
Cultural adaptation and preliminary validation of the qualisex questionnaire for its use in patients with sjögren's syndrome and fibromyalgia in italy 29
Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies 25
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 24
Ovarian reserve in patients with Sjögren's syndrome: a cross-sectional study 21
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors. results from a monocentric cohort 19
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis. results from the observational GCAGE study on a large cohort of 1004 patients 18
Clinical and histological features of patients with primary sjögren's syndrome and autoimmune thyroiditis. a national multicentre cross-sectional study 18
Response to: `correspondence on `{SARS}-{CoV}-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases. a message for rheumatologists'' by smerilli et al 15
Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies 15
PASSing to the patient side. early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with janus kinase inhibitors 15
Protenuria in SLE:. is it always lupus 14
null 14
Presentation and diagnosis of adult-onset Still's disease: the implications of current and emerging markers in overcoming the diagnostic challenge 10
Significance of anti-La/SSB antibodies in primary sjogren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy 10
COVID-19 gone bad. a new character in the spectrum of the hyperferritinemic syndrome 8
What about glucocorticoids in primary Sjögren's syndrome? 3
Totale 4.678
Categoria #
all - tutte 16.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.680


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020164 0 0 0 0 0 0 0 0 73 43 27 21
2020/2021340 37 22 19 11 0 13 19 36 57 45 25 56
2021/2022808 14 32 64 75 87 51 15 50 77 53 153 137
2022/2023849 140 211 80 79 75 58 16 53 75 17 30 15
2023/2024506 24 59 36 33 49 75 30 25 20 55 51 49
2024/2025997 35 69 104 114 126 115 95 81 258 0 0 0
Totale 4.678